Your browser doesn't support javascript.
loading
A case of palmoplantar pustular psoriasis induced by hydroxychloroquine in a patient with systemic lupus erythematosus.
Karaalioglu, Bilgin; Yildirim, Fatih; Mutlu, Melek Yalçin; Akkuzu, Gamze; Özgür, Duygu Sevinç; Bes, Cemal.
  • Karaalioglu B; Department of Rheumatology, University of Health Sciences Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey.
  • Yildirim F; Department of Rheumatology, University of Health Sciences Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey.
  • Mutlu MY; Department of Rheumatology, University of Health Sciences Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey.
  • Akkuzu G; Department of Rheumatology, University of Health Sciences Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey.
  • Özgür DS; Department of Rheumatology, University of Health Sciences Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey.
  • Bes C; Department of Rheumatology, University of Health Sciences Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey.
Int J Rheum Dis ; 25(10): 1200-1202, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35922392
ABSTRACT
Palmoplantar pustular psoriasis (PPP) is a rare clinical form of psoriasis. It is usually seen on the palms and soles, and affects patients' quality of life. In most cases, topical or systemic treatments are not sufficiently effective, so management of PPP is generally difficult. Hydroxychloroquine (HQ) is an antimalarial drug that is widely used in many autoimmune rheumatic diseases, mainly in systemic lupus erythematosus (SLE). Several reports describe the induction and exacerbation of psoriasis by HQ. Within this report, we aimed to put emphasis on considering possible drug effects by presenting a case of PPP, induced by HQ.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Lupus Eritematoso Sistémico / Antimaláricos Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Lupus Eritematoso Sistémico / Antimaláricos Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article